Financial Advisors Network’s Biogen BIIB Stock Holding History

Financial Advisors Network’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-9,548	Closed	-$2.29M	–	130
2021 Q4	$2.29M	Buy	9,548 +891	+10%	+$229K	0.52%	44
2021 Q3	$2.34M	Buy	8,657 +2,075	+32%	+$680K	0.54%	43
2021 Q2	$2.28M	Sell	6,582 -259	-4%	-$78.5K	0.67%	30
2021 Q1	$1.91M	Buy	+6,841	New	+$1.84M	0.62%	39

Other funds holding BIIB

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return

Financial Advisors Network's BIIB Position: Q1 2022 in Review

Financial Advisors Network sold out of Biogen (BIIB) in Q1 2022, closing a stake of 9,548 shares — an estimated $2.29M sold.

Financial Advisors Network first reported a position in BIIB in Q1 2021 and held it in 4 quarters. The position peaked at $2.34M in Q3 2021. 952 funds tracked by Wall St. Rank hold BIIB as of Q1 2022.

Financial Advisors Network reported no remaining Biogen position as of Q1 2022 after selling out during the quarter.
Financial Advisors Network sold 9,548 Biogen shares in Q1 2022, an estimated $2.29M.
Financial Advisors Network first reported a position in Biogen in Q1 2021 and held it in 4 quarters.
Financial Advisors Network's Biogen position peaked at $2.34M in Q3 2021.
952 funds tracked by Wall St. Rank held Biogen as of Q1 2022.

Based on Financial Advisors Network's 13F filing for Q1 2022, filed 13 May 2022.